Under construction – not a live service
Sign in
Taking people in MalaysiaNo phase

Follows people treated for narrowing of the left main heart artery

Follows adults with left main coronary artery narrowing treated with medicine, stents or bypass surgery.

Plain-language title generated from the registry record
Registry title: Observational Study for Left Main Disease Treatment

Key facts

Where
Kuching, MalaysiaSee the site

Where in Malaysia

  • Sarawak General HospitalKuching, MalaysiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Seung-Jung Park
Trial code
NCT01341327
Record updated
15 October 2026
Original description
The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.Read full original descriptionShow less

A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT

The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.

Inclusion: Significant unprotected left main stenosis (>50% by visual estimation); The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery; No limitation of clinical or lesion characteristics; Age >18 years; The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Exclusion: Protected left main stenosis.

ClinicalTrials.gov NCT01341327